Abstract
Background Postural stepping is an important strategy for recovery of balance in response to postural perturbations. It is disrupted by Parkinson’s disease (PD) and other conditions. The nature of this disruption remains poorly understood. Understanding the motor control nature of this impairment can guide the development of novel interventions.
Objectives To identify the motor control abnormalities responsible for parkinsonian impairment of postural stepping.
Methods We studied four groups of participants: control, aged, PD, and normal-pressure hydrocephalus (NPH). We performed kinematic analysis of postural stepping by recording participants’ body motion during a modified version of the clinical pull test, which was performed multiple times with different amounts of pulling forcefulness.
Results Successful postural stepping in the control group was accompanied by linear scaling of their first step’s length and latency to the body’s initial motion: more forceful pulls caused larger initial body acceleration, which resulted in longer steps that began earlier. PD patients exhibited reduced scaling of step length: they maintained normal reaction time but took steps that were inadequately short. Reduced step length scaling was present, but less severe, in aged individuals, and was more severe in NPH patients. Aged individuals and PD patients exhibited partial compensation for reduced step length scaling: their step length included a component that was independent of initial body acceleration, which was absent in control and NPH groups.
Conclusions the impairment of postural stepping caused by PD and related conditions is due to inadequate scaling of movement amplitude and is thus a form of hypokinesia.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by grants from the Parkinson's Disease Foundation and the Doris Duke Charitable Foundation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol was approved by the Columbia University Medical Center Institutional Review Board.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data and custom software routines are available by contacting the corresponding author.
